Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Annales De Pathologie|April 20, 2004
[Management of ductal carcinoma in situ by the pathologist: current questions]Laurent Arnould, Yves Caron, Brigitte Sigal-Zafrani
Psycho-Oncology|May 16, 2015
Breast cancer survivors' perceived medical communication competence and satisfaction with care at the end of treatmentAnne Brédart, Jean-Luc Kop, Chavie Fiszer, et al.
Annales De Pathologie|April 20, 2004
[Lobular neoplasia]Brigitte Sigal-Zafrani, Anne Vincent-Salomon, Frédérique Penault-Llorca, et al.
American Journal of Clinical Oncology|March 25, 2009
Familial breast cancer: clinical response to induction chemotherapy or radiotherapy related to BRCA1/2 mutations statusAlain Fourquet, Dominique Stoppa-Lyonnet, Youlia M Kirova, et al.
Breast Cancer Research and Treatment|July 13, 2007
No evidence of human papillomavirus DNA sequences in invasive breast carcinomaPatricia de Cremoux, Martine Thioux, Ingrid Lebigot, et al.
Genes, Chromosomes & Cancer|March 8, 2005
Ductal breast carcinoma develops through different patterns of chromosomal evolutionRomain Molist, Michele Gerbault-Seureau, Xavier Sastre-Garau, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 18, 2008
Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrumMarick Laé, Paul Fréneaux, Xavier Sastre-Garau, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2005
Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapyYoulia M Kirova, Dominique Stoppa-Lyonnet, Alexia Savignoni, et al.
AJR. American Journal of Roentgenology|September 24, 2004
MRI for surgical planning in patients with breast cancer who undergo preoperative chemotherapyFabienne Thibault, Claude Nos, Martine Meunier, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 12, 2003
Overexpression/amplification of HER-2/neu is uncommon in invasive carcinoma of the uterine cervixChristophe Rosty, Jérôme Couturier, Anne Vincent-Salomon, et al.
Pageof 8